Huiqiang Zhou

683 total citations
21 papers, 540 citations indexed

About

Huiqiang Zhou is a scholar working on Molecular Biology, Nutrition and Dietetics and Endocrine and Autonomic Systems. According to data from OpenAlex, Huiqiang Zhou has authored 21 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Nutrition and Dietetics and 4 papers in Endocrine and Autonomic Systems. Recurrent topics in Huiqiang Zhou's work include Bone Metabolism and Diseases (5 papers), Regulation of Appetite and Obesity (4 papers) and Biochemical Analysis and Sensing Techniques (4 papers). Huiqiang Zhou is often cited by papers focused on Bone Metabolism and Diseases (5 papers), Regulation of Appetite and Obesity (4 papers) and Biochemical Analysis and Sensing Techniques (4 papers). Huiqiang Zhou collaborates with scholars based in United States, Netherlands and China. Huiqiang Zhou's co-authors include Anthony L. Handlon, Francis X. Tavares, Joyce A. Boucheron, Scott H. Dickerson, Stephen A. Thomson, Frank Preugschat, Prasad Dande, Hung‐wen Liu, Barry Gold and Andrew J. Peat and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Annals of Oncology.

In The Last Decade

Huiqiang Zhou

21 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiqiang Zhou United States 14 309 200 59 57 52 21 540
Dulce Garrido United States 11 222 0.7× 183 0.9× 31 0.5× 38 0.7× 21 0.4× 18 427
John A. Wos United States 13 249 0.8× 285 1.4× 93 1.6× 81 1.4× 27 0.5× 34 565
Pingchen Fan United States 13 262 0.8× 219 1.1× 29 0.5× 27 0.5× 12 0.2× 15 548
Malcolm J. Kavarana United States 11 262 0.8× 53 0.3× 71 1.2× 98 1.7× 42 0.8× 14 452
Xuyuan Gu United States 13 259 0.8× 266 1.3× 58 1.0× 61 1.1× 25 0.5× 22 409
Feroze Ujjainwalla United States 16 299 1.0× 523 2.6× 49 0.8× 65 1.1× 75 1.4× 28 952
J. Elizabeth Pease United Kingdom 9 211 0.7× 165 0.8× 43 0.7× 14 0.2× 126 2.4× 17 458
Xiaojing Yuan China 15 314 1.0× 82 0.4× 25 0.4× 11 0.2× 32 0.6× 26 557
Mark D. Andrews United Kingdom 14 228 0.7× 290 1.4× 8 0.1× 19 0.3× 40 0.8× 25 664
Lilia Weizel Germany 16 368 1.2× 174 0.9× 19 0.3× 7 0.1× 46 0.9× 34 704

Countries citing papers authored by Huiqiang Zhou

Since Specialization
Citations

This map shows the geographic impact of Huiqiang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiqiang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiqiang Zhou more than expected).

Fields of papers citing papers by Huiqiang Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiqiang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiqiang Zhou. The network helps show where Huiqiang Zhou may publish in the future.

Co-authorship network of co-authors of Huiqiang Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Huiqiang Zhou. A scholar is included among the top collaborators of Huiqiang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiqiang Zhou. Huiqiang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sparks, Steven M., et al.. (2016). Identification of nonabsorbable inhibitors of the scavenger receptor-BI (SR-BI) for tissue-specific administration. Bioorganic & Medicinal Chemistry Letters. 26(8). 1901–1904. 4 indexed citations
3.
Zhou, Huiqiang, et al.. (2010). Synthesis and SAR of Benzisothiazole- and Indolizine-β-d-glucopyranoside Inhibitors of SGLT2. ACS Medicinal Chemistry Letters. 1(1). 19–23. 42 indexed citations
4.
Tavares, Francis X., Kamal Albarazanji, Michael J. Bishop, et al.. (2006). 6-(4-Chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-Based Melanin-Concentrating Hormone Receptor 1 Antagonist. Journal of Medicinal Chemistry. 49(24). 7108–7118. 17 indexed citations
5.
Hertzog, Donald L., Kamal Albarazanji, Eric C. Bigham, et al.. (2006). The discovery and optimization of pyrimidinone-containing MCH R1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(18). 4723–4727. 39 indexed citations
6.
McGuigan, Christopher, Sheila Srinivasan, Yikang Wang, et al.. (2006). Application of Phosphoramidate ProTide Technology Significantly Improves Antiviral Potency of Carbocyclic Adenosine Derivatives. Journal of Medicinal Chemistry. 49(24). 7215–7226. 51 indexed citations
7.
Handlon, Anthony L. & Huiqiang Zhou. (2006). Melanin-Concentrating Hormone-1 Receptor Antagonists for the Treatment of Obesity. Journal of Medicinal Chemistry. 49(14). 4017–4022. 39 indexed citations
8.
Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2006). Acyclic, orally bioavailable ketone-based cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(1). 22–27. 6 indexed citations
9.
Tavares, Francis X., Kamal Albarazanji, Eric C. Bigham, et al.. (2006). Potent, Selective, and Orally Efficacious Antagonists of Melanin-Concentrating Hormone Receptor 1. Journal of Medicinal Chemistry. 49(24). 7095–7107. 28 indexed citations
10.
Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2005). P2–P3 conformationally constrained ketoamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 15(15). 3540–3546. 27 indexed citations
11.
Peat, Andrew J., Joyce A. Boucheron, Scott H. Dickerson, et al.. (2004). Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(9). 2121–2125. 58 indexed citations
12.
Tavares, Francis X., David N. Deaton, Aaron B. Miller, et al.. (2004). Potent and Selective Ketoamide-Based Inhibitors of Cysteine Protease, Cathepsin K. Journal of Medicinal Chemistry. 47(21). 5049–5056. 8 indexed citations
13.
Tavares, Francis X., Joyce A. Boucheron, Scott H. Dickerson, et al.. (2004). N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy. Journal of Medicinal Chemistry. 47(19). 4716–4730. 75 indexed citations
14.
Barrett, David G., John G. Catalano, David N. Deaton, et al.. (2004). Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 14(10). 2543–2546. 10 indexed citations
15.
Tavares, Francis X., David N. Deaton, Anne M. Hassell, et al.. (2003). Design of Potent, Selective, and Orally Bioavailable Inhibitors of Cysteine Protease Cathepsin K. Journal of Medicinal Chemistry. 47(3). 588–599. 37 indexed citations
16.
Chang, Cheng‐Wei Tom, David A. Johnson, Vahe Bandarian, et al.. (2000). Characterization of a Unique Coenzyme B6 Radical in the Ascarylose Biosynthetic Pathway. Journal of the American Chemical Society. 122(17). 4239–4240. 14 indexed citations
17.
Zhou, Huiqiang, et al.. (1998). Control over the Localization of Positive Charge in DNA:  The Effect on Duplex DNA and RNA Stability. Journal of the American Chemical Society. 120(46). 12165–12166. 41 indexed citations
18.
Yang, Ding‐Yah, et al.. (1997). 3-Deoxy-3-fluoropyridoxamine 5‘-Phosphate:  Synthesis and Chemical and Biological Properties of a Coenzyme B6 Analog. Journal of the American Chemical Society. 119(8). 1809–1817. 15 indexed citations
20.
Zhou, Wei‐Shan, et al.. (1990). Studies on the Synthesis of Steroidal Plant-Growth Hormones; XVIII. A Convenient Route to 26,27-Bisnorbrassinolide. Synthesis. 1990(11). 1073–1075. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026